Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute …

AH Elmaagacli, NK Steckel, M Koldehoff… - Blood, The Journal …, 2011 - ashpublications.org
AH Elmaagacli, NK Steckel, M Koldehoff, Y Hegerfeldt, R Trenschel, M Ditschkowski…
Blood, The Journal of the American Society of Hematology, 2011ashpublications.org
The impact of early human cytomegalovirus (HCMV) replication on leukemic recurrence was
evaluated in 266 consecutive adult (median age, 47 years; range, 18-73 years) acute
myeloid leukemia patients, who underwent allogeneic stem cell transplantation (alloSCT)
from 10 of 10 high-resolution human leukocyte Ag-identical unrelated (n= 148) or sibling (n=
118) donors. A total of 63% of patients (n= 167) were at risk for HCMV reactivation by patient
and donor pretransplantation HCMV serostatus. In 77 patients, first HCMV replication as …
Abstract
The impact of early human cytomegalovirus (HCMV) replication on leukemic recurrence was evaluated in 266 consecutive adult (median age, 47 years; range, 18-73 years) acute myeloid leukemia patients, who underwent allogeneic stem cell transplantation (alloSCT) from 10 of 10 high-resolution human leukocyte Ag-identical unrelated (n = 148) or sibling (n = 118) donors. A total of 63% of patients (n = 167) were at risk for HCMV reactivation by patient and donor pretransplantation HCMV serostatus. In 77 patients, first HCMV replication as detected by pp65-antigenemia assay developed at a median of 46 days (range, 25-108 days) after alloSCT. Taking all relevant competing risk factors into account, the cumulative incidence of hematologic relapse at 10 years after alloSCT was 42% (95% confidence interval [CI], 35%-51%) in patients without opposed to 9% (95% CI, 4%-19%) in patients with early pp65-antigenemia (P < .0001). A substantial and independent reduction of the relapse risk associated with early HCMV replication was confirmed by multivariate analysis using time-dependent covariate functions for grades II to IV acute and chronic graft-versus-host disease, and pp65-antigenemia (hazard ratio = 0.2; 95% CI, 0.1-0.4, P < .0001). This is the first report that demonstrates an independent and substantial reduction of the leukemic relapse risk after early replicative HCMV infection in a homogeneous population of adult acute myeloid leukemia patients.
ashpublications.org